Oramed Pharmaceuticals Inc banner

Oramed Pharmaceuticals Inc
F:OJU1

Watchlist Manager
Oramed Pharmaceuticals Inc Logo
Oramed Pharmaceuticals Inc
F:OJU1
Watchlist
Price: 3.885 EUR -0.38%
Market Cap: €157.4m

Wall St Price Targets

OJU1 Price Targets Summary
Oramed Pharmaceuticals Inc

Wall Street analysts forecast OJU1 stock price to drop over the next 12 months.

According to Wall Street analysts, the average 1-year price target for OJU1 is 3.133 EUR with a low forecast of 3.102 EUR and a high forecast of 3.225 EUR.

Lowest Forecast
Price Target
3.102 EUR
20% Downside
Average Forecast
Price Target
3.133 EUR
19% Downside
Highest Forecast
Price Target
3.225 EUR
17% Downside
Oramed Pharmaceuticals Inc Competitors:
Price Targets
MZH
Nanofilm Technologies International Ltd
39% Upside

Revenue
Forecast

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss

Gross Profit
Forecast

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss

Operating Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss

Pre-Tax Income
Forecast

N/A
Past Growth
73% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
N/A
Past Growth
73% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss

The compound annual growth rate for Pre-Tax Income over the next 1 year is 73%.

Net Income
Forecast

N/A
Past Growth
55% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
N/A
Past Growth
55% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss

The compound annual growth rate for Net Income over the next 1 year is 55%.

Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is OJU1's stock price target?
Price Target
3.133 EUR

According to Wall Street analysts, the average 1-year price target for OJU1 is 3.133 EUR with a low forecast of 3.102 EUR and a high forecast of 3.225 EUR.

What is the Pre-Tax Income forecast for Oramed Pharmaceuticals Inc?
Projected CAGR
73%

The compound annual growth rate for Pre-Tax Income over the next 1 year is 73%.

What is the Net Income forecast for Oramed Pharmaceuticals Inc?
Projected CAGR
55%

The compound annual growth rate for Net Income over the next 1 year is 55%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett